Physician profile
Michael Hung
NPI 1346774809
$4,358.42
in general payments reported to CMS, 2019-2025
21 companies · $3,474 in 2025
The $3,474 reported for 2025 was more than what 88% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $151 · 2023: $129 · 2024: $604 · 2025: $3,474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,735 · Travel and Lodging: $1,298 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,735.15 |
| Travel and Lodging | $1,297.57 |
| Education | $174.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $2,083.63 | 2025 | Nanoknife |
| Janssen Biotech, INC. | $628.90 | 2024-2025 | Erleada, Akeega, Carvykti |
| Urogen Pharma, INC. | $412.64 | 2023-2025 | Jelmyto |
| Edap Technomed INC | $216.00 | 2024 | |
| Ferring Pharmaceuticals INC. | $211.22 | 2025 | Adstiladrin |
| Boston Scientific Corporation | $186.12 | 2022-2024 | |
| C. R. Bard, INC. & Subsidiaries | $124.37 | 2025 | Bard Urinary Drainage Bag |
| Telix Pharmaceuticals | $87.70 | 2024-2025 | Illuccix |
| Laborie Medical Technologies Corp. | $70.43 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Myriad Genetic Laboratories, INC. | $42.22 | 2025 | Prolaris |
| Civco Medical Instruments | $35.27 | 2024-2025 | |
| Dendreon Pharmaceuticals LLC | $34.44 | 2025 | Provenge |
| Photocure INC | $33.34 | 2025 | Cysview |
| Coloplast Corp | $30.41 | 2025 | |
| Immunitybio, INC. | $29.10 | 2025 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tolmar, INC. | $27.42 | 2025 | Eligard |
| Dentsply Ih Ab | $23.96 | 2025 | Lofric |
| Bayer Healthcare Pharmaceuticals INC. | $22.44 | 2025 | |
| Blue Earth Diagnostics | $22.04 | 2025 | Posluma |
| Progenics Pharmaceuticals, INC. | $19.58 | 2025 | |
| Abbvie INC. | $17.19 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.